Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation.

Chronic obstructive pulmonary disease (COPD) is a smoking-related disease that lacks effective therapies due partly to the poor understanding of disease pathogenesis. The aim of this study was to identify molecular pathways that could be responsible for the damaging consequences of smoking. To do this, we employed Gene Set Enrichment Analysis to analyze differences in global gene expression, which we then related to the pathological changes induced by cigarette smoke (CS). Sprague-Dawley rats were exposed to whole body CS for 1 day and for various periods up to 8 mo. Gene Set Enrichment Analysis of microarray data identified that metabolic processes were most significantly increased early in the response to CS. Gene sets involved in stress response and inflammation were also upregulated. CS exposure increased neutrophil chemokines, cytokines, and proteases (MMP-12) linked to the pathogenesis of COPD. After a transient acute response, the CS-exposed rats developed a distinct molecular signature after 2 wk, which was followed by the chronic phase of the response. During this phase, gene sets related to immunity and defense progressively increased and predominated at the later time points in smoke-exposed rats. Chronic CS inhalation recapitulated many of the phenotypic changes observed in COPD patients including oxidative damage to macrophages, a slowly resolving inflammation, epithelial damage, mucus hypersecretion, airway fibrosis, and emphysema. As such, it appears that metabolic pathways are central to dealing with the stress of CS exposure; however, over time, inflammation and stress response gene sets become the most significantly affected in the chronic response to CS.

[1]  J. Mead,et al.  Mechanics of respiration in unanesthetized guinea pigs. , 1958, The American journal of physiology.

[2]  C. Heckman,et al.  Pathogenesis of Lesions Induced in Rat Lung by Chronic Tobacco Smoke Inhalation , 1982, Journal of the National Cancer Institute.

[3]  P. Morrow,et al.  Possible mechanisms to explain dust overloading of the lungs. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[4]  W. Thurlbeck,et al.  Emphysema Then and Now , 1994 .

[5]  D. Agrawal,et al.  Measurement of bronchoconstriction using whole-body plethysmograph: comparison of freely moving versus restrained guinea pigs. , 1998, Journal of pharmacological and toxicological methods.

[6]  S. Shapiro Requirement for macrophage elastase for emphysema , 1998 .

[7]  R. Abboud,et al.  Time course of neutrophil and macrophage elastinolytic activities in cigarette smoke-induced emphysema , 1998 .

[8]  S. Shibahara,et al.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. , 2000, American journal of human genetics.

[9]  M. Paiva,et al.  N-acetylcysteine prevents cigarette smoke induced small airways alterations in rats. , 2000, The European respiratory journal.

[10]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[11]  F. Hahn,et al.  Influence of exposure concentration or dose on the distribution of particulate material in rat and human lungs. , 2001, Environmental health perspectives.

[12]  L. Fabbri,et al.  Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers. , 2001, American journal of respiratory and critical care medicine.

[13]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[14]  J. Fozard,et al.  Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[15]  S. Shapiro,et al.  Chronic obstructive pulmonary disease • 3: Experimental animal models of pulmonary emphysema , 2002, Thorax.

[16]  J. Giddings,et al.  Development and validation of a lectin-based assay for the quantitation of rat respiratory mucin. , 2002, Novartis Foundation symposium.

[17]  A. Churg,et al.  Animal models of cigarette smoke-induced COPD. , 2002, Chest.

[18]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[19]  P. Kirkham,et al.  Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. , 2003, Free radical biology & medicine.

[20]  A. Nel,et al.  Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. , 2002, Environmental health perspectives.

[21]  Irfan Rahman,et al.  Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. , 2004, American journal of respiratory cell and molecular biology.

[22]  A. Bosio,et al.  Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke. , 2003, Carcinogenesis.

[23]  Irina Petrache,et al.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. , 2004, The Journal of clinical investigation.

[24]  Dirkje S Postma,et al.  Acute effects of cigarette smoking on inflammation in healthy intermittent smokers , 2005, Respiratory research.

[25]  Y. Ishigatsubo,et al.  Heme oxygenase-1 inhibits cigarette smoke-induced increase in the tracheal mucosal permeability in guinea pigs in vivo , 2005, Inflammation Research.

[26]  Y. Nagashima,et al.  Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lungs attenuates elastase-induced pulmonary emphysema in mice. , 2005, Human gene therapy.

[27]  P. Gustin,et al.  Comparison between pulmonary resistance and Penh in anaesthetised rats with tracheal diameter reduction and after carbachol inhalation. , 2005, Journal of pharmacological and toxicological methods.

[28]  Wei Liu,et al.  Role of CCR5 in IFN-γ–induced and cigarette smoke–induced emphysema , 2005 .

[29]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[30]  R. Pauwels,et al.  Time course of cigarette smoke-induced pulmonary inflammation in mice , 2005, European Respiratory Journal.

[31]  Helinor J Johnston,et al.  Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[32]  M. Belvisi,et al.  Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation. , 2005, American journal of respiratory and critical care medicine.

[33]  A. Heguy,et al.  Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking , 2006, Journal of Molecular Medicine.

[34]  J. Hogg Why does airway inflammation persist after the smoking stops? , 2006, Thorax.

[35]  S. Reddy,et al.  Nrf2 defends the lung from oxidative stress. , 2006, Antioxidants & redox signaling.

[36]  J. Fozard,et al.  In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action , 2006, Journal of Pharmacology and Experimental Therapeutics.

[37]  J. Szustakowski,et al.  Identification of novel pathway regulation during myogenic differentiation. , 2006, Genomics.

[38]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[39]  J. Maurer Emphysema Lung Tissue Gene Expression Profiling , 2006 .

[40]  Christopher S. Stevenson,et al.  Aerobic capacity, oxidant stress, and chronic obstructive pulmonary disease--a new take on an old hypothesis. , 2006, Pharmacology & therapeutics.